OPMD and HBV seems clearly where all the focus and strength lies now Surprisingly, both have shown impressive pre-clinical success, due to HBV patents improvements made over many years 2015'16 and 18 OPMD due to its new "silence and replace technology and the teams vast experience. Both of course with unmet treatments available
BLT Price at posting:
5.4¢ Sentiment: Hold Disclosure: Held